These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
485 related articles for article (PubMed ID: 31150700)
1. Mohs micrographic surgery for melanoma: A prospective multicenter study. Ellison PM; Zitelli JA; Brodland DG J Am Acad Dermatol; 2019 Sep; 81(3):767-774. PubMed ID: 31150700 [TBL] [Abstract][Full Text] [Related]
2. The use of Mohs micrographic surgery (MMS) for melanoma in situ (MIS) of the trunk and proximal extremities. Stigall LE; Brodland DG; Zitelli JA J Am Acad Dermatol; 2016 Nov; 75(5):1015-1021. PubMed ID: 27473456 [TBL] [Abstract][Full Text] [Related]
3. Mohs Micrographic Surgery Using MART-1 Immunostain in the Treatment of Invasive Melanoma and Melanoma In Situ. Valentín-Nogueras SM; Brodland DG; Zitelli JA; González-Sepúlveda L; Nazario CM Dermatol Surg; 2016 Jun; 42(6):733-44. PubMed ID: 27158886 [TBL] [Abstract][Full Text] [Related]
4. Low recurrence rates for in situ and invasive melanomas using Mohs micrographic surgery with melanoma antigen recognized by T cells 1 (MART-1) immunostaining: tissue processing methodology to optimize pathologic staging and margin assessment. Etzkorn JR; Sobanko JF; Elenitsas R; Newman JG; Goldbach H; Shin TM; Miller CJ J Am Acad Dermatol; 2015 May; 72(5):840-50. PubMed ID: 25774012 [TBL] [Abstract][Full Text] [Related]
5. Mohs micrographic surgery with melanoma antigen recognized by T cells 1 (MART-1) immunostaining for atypical intraepidermal melanocytic proliferation. Etzkorn JR; Jew OS; Shin TM; Sobanko JF; Neal DE; Miller CJ J Am Acad Dermatol; 2018 Dec; 79(6):1109-1116.e1. PubMed ID: 30003986 [TBL] [Abstract][Full Text] [Related]
6. Association of Mohs Micrographic Surgery vs Wide Local Excision With Overall Survival Outcomes for Patients With Melanoma of the Trunk and Extremities. Demer AM; Hanson JL; Maher IA; Liszewski W JAMA Dermatol; 2021 Jan; 157(1):84-89. PubMed ID: 33084853 [TBL] [Abstract][Full Text] [Related]
7. Comparison of MITF and Melan-A Immunohistochemistry During Mohs Surgery for Lentigo Maligna-Type Melanoma In Situ and Lentigo Maligna Melanoma. Christensen KN; Hochwalt PC; Hocker TL; Roenigk RK; Brewer JD; Baum CL; Otley CC; Arpey CJ Dermatol Surg; 2016 Feb; 42(2):167-75. PubMed ID: 26771682 [TBL] [Abstract][Full Text] [Related]
8. The Current State of Mohs Surgery for the Treatment of Melanoma: A Nationwide Cross-Sectional Survey of Mohs Surgeons. Siscos SM; Neill BC; Seger EW; Hooton TA; Hocker TLH Dermatol Surg; 2020 Oct; 46(10):1267-1271. PubMed ID: 32740213 [TBL] [Abstract][Full Text] [Related]
9. Excision margins for melanoma in situ on the head and neck-A single-center 10-year retrospective review of treatment with Mohs micrographic surgery. Tate JA; Matsumoto A; Greif C; Lim J; Nijhawan RI; Srivastava D J Am Acad Dermatol; 2024 Jun; 90(6):1226-1231. PubMed ID: 38253130 [TBL] [Abstract][Full Text] [Related]
10. Treating melanoma in situ and lentigo maligna with Mohs micrographic surgery in Australia. Foxton GC; Elliott TG; Litterick KA Australas J Dermatol; 2019 Feb; 60(1):33-37. PubMed ID: 29932208 [TBL] [Abstract][Full Text] [Related]
11. Mohs micrographic surgery: a cost analysis. Cook J; Zitelli JA J Am Acad Dermatol; 1998 Nov; 39(5 Pt 1):698-703. PubMed ID: 9810885 [TBL] [Abstract][Full Text] [Related]
12. Surgical margins for excision of primary cutaneous melanoma. Zitelli JA; Brown CD; Hanusa BH J Am Acad Dermatol; 1997 Sep; 37(3 Pt 1):422-9. PubMed ID: 9308558 [TBL] [Abstract][Full Text] [Related]
13. Long-term outcomes of Mohs micrographic surgery for invasive melanoma of the trunk and proximal portion of the extremities. Burnett ME; Brodland DG; Zitelli JA J Am Acad Dermatol; 2021 Mar; 84(3):661-668. PubMed ID: 32763327 [TBL] [Abstract][Full Text] [Related]
14. Cutaneous head and neck melanoma treated with Mohs micrographic surgery. Bricca GM; Brodland DG; Ren D; Zitelli JA J Am Acad Dermatol; 2005 Jan; 52(1):92-100. PubMed ID: 15627086 [TBL] [Abstract][Full Text] [Related]
15. Treatment of cutaneous melanoma of the face by Mohs micrographic surgery. Bienert TN; Trotter MJ; Arlette JP J Cutan Med Surg; 2003; 7(1):25-30. PubMed ID: 12447624 [TBL] [Abstract][Full Text] [Related]
16. Mohs micrographic surgery with MART-1 immunostaining has durable low local recurrence rates for in situ and invasive melanomas. Shin TM; Nugent S; Aizman L; Weiner DM; O'Malley V; Sobanko JF; Etzkorn JR; Chu EY; Elenitsas R; Giordano CN; Higgins Ii HW; Miller CJ J Am Acad Dermatol; 2021 Jan; 84(1):196-198. PubMed ID: 32339704 [No Abstract] [Full Text] [Related]
17. Slow Mohs Micrographic Surgery for Acral Melanoma Treatment in Korean Patients. Seo J; Oh Y; Kim SK; Roh MR; Chung KY Dermatol Surg; 2021 Feb; 47(2):e42-e46. PubMed ID: 33481431 [TBL] [Abstract][Full Text] [Related]
18. Comparison of staged excision and Mohs micrographic surgery with and without MART-1 immunostains for surgical treatment of melanoma of the head, neck, and special sites: A retrospective cohort study. Wilson JG; German R; Hamann CR; Vidal NY; LeBoeuf M J Am Acad Dermatol; 2021 Jan; 84(1):192-194. PubMed ID: 32348827 [No Abstract] [Full Text] [Related]
19. Mohs micrographic surgery for melanoma: a case series, a comparative study of immunostains, an informative case report, and a unique mapping technique. Albertini JG; Elston DM; Libow LF; Smith SB; Farley MF Dermatol Surg; 2002 Aug; 28(8):656-65. PubMed ID: 12174054 [TBL] [Abstract][Full Text] [Related]
20. Digit-Sparing Mohs Surgery for Melanoma. Terushkin V; Brodland DG; Sharon DJ; Zitelli JA Dermatol Surg; 2016 Jan; 42(1):83-93. PubMed ID: 26655701 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]